Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam vs Older AEDs in Newly Diagnosed Epilepsy
NCT00175903Phase 3Completed
- Sponsor
- UCB
- Start
- Feb 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 24
01
Overview
Phase 3, randomised, open-label trial of levetiracetam in epilepsy (2 arms), sponsored by UCB. Primary endpoint: Time to withdrawal from study medication at 52 weeks. Started Feb 2005; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00175903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175903.